Allstate Investment Management’s Boston Scientific BSX Stock Holding History

Allstate Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2.98M	Buy	+64,451	New	+$2.79M	0.09%	150

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Allstate Investment Management's BSX Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Boston Scientific (BSX) in Q4 2022: 64,451 shares worth $2.98M. The stake represents 0.09% of the portfolio and ranks #150 among its holdings.

930 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Allstate Investment Management held 64,451 shares of Boston Scientific worth $2.98M as of Q4 2022.
Boston Scientific was a new Allstate Investment Management position in Q4 2022.
Boston Scientific made up 0.09% of Allstate Investment Management's portfolio in Q4 2022, its #150 holding.
930 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.